Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ilant Health vs VivioMD

Ilant Health
Graded #407

Lower grade

vs+0.5
VivioMD
Graded #401

Higher grade

The verdict

VivioMD takes it — 57.3/100 to 56.8/100, but only just.

VivioMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth wellness provider that does not currently offer GLP-1 medications. Ilant Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightIlant Health +3
83
80
Labs & monitoringIlant Health +8
61
53
FulfillmentVivioMD +19
62
81
Contract termsEven
55
55
Ilant Health · left barVivioMD · right bar

The numbers

MetricIlant HealthVivioMD
WeighScore56.8/10057.3/100
GradeCC
Scorecard rank#407#401
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ilant Health

Graded #407 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1
VivioMD

Graded #401 · C

Strengths

  • Telehealth convenience
  • Physician-supervised program

Where it loses points

  • GLP-1 medications not currently offered

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard